Quoin Gross Profit from 2010 to 2024

QNRX Stock

USD 0.60 0.01 1.69%

Quoin Pharmaceuticals Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about -108.6 K in 2024. Gross Profit is the profit Quoin Pharmaceuticals Ltd makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

-103.4 K

Current Value

-108.6 K

Quarterly Volatility

83.9 K

Credit Downgrade

Yuan Drop

Covid

Check Quoin Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quoin Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 4 M, Total Revenue of 0.0 or Other Operating Expenses of 7 M, as well as many indicators such as Dividend Yield of 7.58, Ptb Ratio of 0.74 or Book Value Per Share of 5.97. Quoin financial statements analysis is a perfect complement when working with Quoin Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Quoin Pharmaceuticals Correlation against competitors.

Latest Quoin Pharmaceuticals' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Quoin Pharmaceuticals Ltd over the last few years. Gross profit is a required income statement account that reflects total revenue of Quoin Pharmaceuticals Ltd minus its cost of goods sold. It is profit before Quoin Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Quoin Pharmaceuticals' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quoin Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Quoin Gross Profit Regression Statistics

	Arithmetic Mean	(218,108)
	Coefficient Of Variation	(38.48)
	Mean Deviation	75,463
	Median	(280,000)
	Standard Deviation	83,938
	Sample Variance	7B
	Range	176.6K
	R-Value	0.85
	Mean Square Error	2.1B
	R-Squared	0.73
	Significance	0.000056
	Slope	15,986
	Total Sum of Squares	98.6B

Quoin Gross Profit History

	2024	-108.6 K
	2023	-103.4 K
	2022	-103.6 K
	2021	-104.1 K
	2020	-104.8 K
	2019	-227.1 K

Other Fundumenentals of Quoin Pharmaceuticals

Gross Profit Margin

Quoin Pharmaceuticals Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Current Assets	Net Tangible Assets	Current Deferred Revenue	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Short Term Debt	Intangible Assets	Common Stock	Net Invested Capital	Short Long Term Debt	Net Working Capital
Total Assets		0.92	-0.1	0.56	0.05	0.31	-0.23	-0.02	0.01	-0.22	-0.09	0.06	-0.05	0.02	0.01	0.02
Total Stockholder Equity	0.92		-0.27	0.3	-0.1	0.57	-0.27	-0.24	0.08	-0.52	-0.26	0.27	0.08	-0.16	0.08	-0.15
Net Debt	-0.1	-0.27		0.18	0.13	-0.69	0.08	0.7	0.1	0.5	1.0	-0.2	0.14	0.19	0.1	0.15
Total Current Assets	0.56	0.3	0.18		0.69	0.07	-0.54	0.63	-0.33	0.43	0.19	-0.63	-0.64	0.7	-0.33	0.69
Net Tangible Assets	0.05	-0.1	0.13	0.69		0.08	-0.79	0.78	-0.74	0.66	0.13	-0.96	-0.95	0.99	-0.74	0.99
Current Deferred Revenue	0.31	0.57	-0.69	0.07	0.08		-0.58	-0.37	-0.14	-0.68	-0.68	0.16	-0.2	-0.02	-0.14	0.0
Retained Earnings	-0.23	-0.27	0.08	-0.54	-0.79	-0.58		-0.48	0.7	-0.1	0.08	0.62	0.73	-0.7	0.7	-0.71
Accounts Payable	-0.02	-0.24	0.7	0.63	0.78	-0.37	-0.48		-0.38	0.79	0.7	-0.8	-0.6	0.83	-0.38	0.8
Net Receivables	0.01	0.08	0.1	-0.33	-0.74	-0.14	0.7	-0.38		-0.43	0.1	0.73	0.69	-0.66	1.0	-0.67
Total Liab	-0.22	-0.52	0.5	0.43	0.66	-0.68	-0.1	0.79	-0.43		0.5	-0.82	-0.58	0.74	-0.43	0.73
Short Term Debt	-0.09	-0.26	1.0	0.19	0.13	-0.68	0.08	0.7	0.1	0.5		-0.2	0.14	0.19	0.1	0.15
Intangible Assets	0.06	0.27	-0.2	-0.63	-0.96	0.16	0.62	-0.8	0.73	-0.82	-0.2		0.91	-0.96	0.73	-0.96
Common Stock	-0.05	0.08	0.14	-0.64	-0.95	-0.2	0.73	-0.6	0.69	-0.58	0.14	0.91		-0.95	0.69	-0.96
Net Invested Capital	0.02	-0.16	0.19	0.7	0.99	-0.02	-0.7	0.83	-0.66	0.74	0.19	-0.96	-0.95		-0.66	1.0
Short Long Term Debt	0.01	0.08	0.1	-0.33	-0.74	-0.14	0.7	-0.38	1.0	-0.43	0.1	0.73	0.69	-0.66		-0.67
Net Working Capital	0.02	-0.15	0.15	0.69	0.99	0.0	-0.71	0.8	-0.67	0.73	0.15	-0.96	-0.96	1.0	-0.67

Click cells to compare fundamentals

About Quoin Pharmaceuticals Financial Statements

Quoin Pharmaceuticals investors use historical fundamental indicators, such as Quoin Pharmaceuticals' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quoin Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	-103.4 K	-108.6 K
Gross Profit Margin	1.30	1.10

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Quoin Stock Analysis

When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC